Chembond Chemicals Past Earnings Performance
Past criteria checks 5/6
Chembond Chemicals has been growing earnings at an average annual rate of 25.3%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 11.8% per year. Chembond Chemicals's return on equity is 13.9%, and it has net margins of 10.4%.
Key information
25.3%
Earnings growth rate
25.3%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 11.8% |
| Return on equity | 13.9% |
| Net Margin | 10.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Should You Be Adding Chembond Chemicals (NSE:CHEMBOND) To Your Watchlist Today?
Dec 14
Here's What To Make Of Chembond Chemicals' (NSE:CHEMBOND) Decelerating Rates Of Return
Jan 20A Look At The Intrinsic Value Of Chembond Chemicals Limited (NSE:CHEMBOND)
Nov 19Robust Earnings May Not Tell The Whole Story For Chembond Chemicals (NSE:CHEMBOND)
Jul 06Earnings Not Telling The Story For Chembond Chemicals Limited (NSE:CHEMBOND)
May 26Is Chembond Chemicals (NSE:CHEMBOND) Likely To Turn Things Around?
Mar 08Chembond Chemicals Limited (NSE:CHEMBOND) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Jan 14Read This Before Selling Chembond Chemicals Limited (NSE:CHEMBOND) Shares
Dec 19
Should You Be Impressed By Chembond Chemicals' (NSE:CHEMBOND) Returns on Capital?
Nov 18Are Dividend Investors Making A Mistake With Chembond Chemicals Limited (NSE:CHEMBOND)?
Oct 14How Much Are Chembond Chemicals Limited (NSE:CHEMBOND) Insiders Spending On Buying Shares?
Aug 22Revenue & Expenses BreakdownBeta
How Chembond Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4,622 | 479 | 822 | 0 |
| 30 Sep 23 | 4,582 | 425 | 803 | 0 |
| 30 Jun 23 | 4,565 | 347 | 792 | 0 |
| 31 Mar 23 | 4,404 | 247 | 764 | 0 |
| 31 Dec 22 | 4,129 | 166 | 727 | 0 |
| 30 Sep 22 | 3,957 | 107 | 714 | 0 |
| 30 Jun 22 | 3,694 | 78 | 700 | 0 |
| 31 Mar 22 | 3,490 | 139 | 676 | 0 |
| 31 Dec 21 | 3,372 | 169 | 683 | 0 |
| 30 Sep 21 | 3,171 | 230 | 663 | 0 |
| 30 Jun 21 | 3,014 | 214 | 634 | 0 |
| 31 Mar 21 | 2,744 | 203 | 619 | 0 |
| 31 Dec 20 | 2,570 | 92 | 611 | 0 |
| 30 Sep 20 | 2,504 | 32 | 617 | 0 |
| 30 Jun 20 | 2,484 | 15 | 632 | 0 |
| 31 Mar 20 | 2,680 | 19 | 638 | 0 |
| 31 Dec 19 | 2,811 | 129 | 643 | 0 |
| 30 Sep 19 | 2,846 | 145 | 630 | 0 |
| 30 Jun 19 | 2,829 | 162 | 611 | 0 |
| 31 Mar 19 | 3,013 | 173 | 597 | 0 |
| 31 Dec 18 | 3,273 | 194 | 557 | 0 |
| 30 Sep 18 | 3,346 | 211 | 538 | 0 |
| 30 Jun 18 | 3,456 | 220 | 514 | 0 |
| 31 Mar 18 | 3,275 | 220 | 491 | 0 |
| 31 Dec 17 | 2,909 | 97 | 441 | 0 |
| 30 Sep 17 | 2,825 | 54 | 429 | 0 |
| 30 Jun 17 | 2,832 | 74 | 422 | 0 |
| 31 Mar 17 | 2,908 | 193 | 420 | 0 |
| 31 Dec 16 | 2,807 | 35 | 439 | 0 |
| 30 Sep 16 | 2,765 | 137 | 425 | 0 |
| 30 Jun 16 | 2,732 | 145 | 391 | 0 |
| 31 Mar 16 | 2,710 | 1,537 | 409 | 0 |
| 31 Dec 15 | 2,739 | 1,609 | 682 | 12 |
| 30 Sep 15 | 2,862 | 1,527 | 692 | 12 |
| 30 Jun 15 | 2,946 | 1,521 | 703 | 12 |
| 31 Mar 15 | 3,002 | 124 | 430 | 0 |
| 31 Dec 14 | 3,008 | 112 | 671 | 8 |
| 30 Sep 14 | 2,917 | 95 | 662 | 8 |
| 30 Jun 14 | 2,788 | 77 | 653 | 8 |
| 31 Mar 14 | 2,745 | 78 | 646 | 8 |
| 31 Dec 13 | 2,793 | 59 | 608 | 10 |
| 30 Sep 13 | 2,776 | 65 | 601 | 10 |
| 30 Jun 13 | 2,719 | 71 | 590 | 10 |
Quality Earnings: CHEMBOND has high quality earnings.
Growing Profit Margin: CHEMBOND's current net profit margins (10.4%) are higher than last year (4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CHEMBOND's earnings have grown significantly by 25.3% per year over the past 5 years.
Accelerating Growth: CHEMBOND's earnings growth over the past year (188.9%) exceeds its 5-year average (25.3% per year).
Earnings vs Industry: CHEMBOND earnings growth over the past year (188.9%) exceeded the Chemicals industry -6.1%.
Return on Equity
High ROE: CHEMBOND's Return on Equity (13.9%) is considered low.